DIATRIZOATE SODIUM — all Canadian products
9 DINs
0 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is DIATRIZOATE SODIUM, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02180626 | HYPAQUE ORAL LIQUID - 50G/120ML | NYCOMED IMAGING A.S. | Liquid | Rectal; Oral | DIATRIZOATE SODIUM 50 G | Cancelled Post Market | |
| 02026902 | HYPAQUE ORAL LIQUID 50GM/120ML | SANOFI CANADA, INC. | Liquid | Rectal; Oral | DIATRIZOATE SODIUM 50 G | Cancelled Post Market | |
| 02180685 | HYPAQUE ORAL POWDER | GE HEALTHCARE CANADA INC | Powder | Rectal; Oral | DIATRIZOATE SODIUM 997.4 MG | Cancelled Post Market | |
| 02026988 | HYPAQUE ORAL POWDER 0.9974G/G | SANOFI CANADA, INC. | Powder | Rectal; Oral | DIATRIZOATE SODIUM 997.4 MG | Cancelled Post Market | |
| 01905007 | HYPAQUE PWR 100% | STERLING WINTHROP INC. | Powder | Oral | DIATRIZOATE SODIUM 100 % | Cancelled Post Market | |
| 02180650 | HYPAQUE SODIUM 50% - LIQ IV | NYCOMED IMAGING A.S. | Liquid | Intravenous | DIATRIZOATE SODIUM 50 % | Cancelled Post Market | |
| 01902768 | HYPAQUE SODIUM 50% LIQ | STERLING WINTHROP INC. | Liquid | Intravenous | DIATRIZOATE SODIUM 50 % | Cancelled Post Market | |
| 02017784 | HYPAQUE SODIUM LIQ 50% | SANOFI CANADA, INC. | Liquid | Intravenous | DIATRIZOATE SODIUM 50 % | Cancelled Post Market | |
| 02180677 | HYPAQUE-M 76% | AMERSHAM HEALTH INC | Solution | Intravenous; Intra-Arterial | DIATRIZOATE SODIUM 10 %; DIATRIZOATE MEGLUMINE 66 % | Cancelled Post Market |
Browse other molecules: